KR20130037154A - Mushroom extract manufacturing method of anti-cancer efficiency - Google Patents
Mushroom extract manufacturing method of anti-cancer efficiency Download PDFInfo
- Publication number
- KR20130037154A KR20130037154A KR1020120078662A KR20120078662A KR20130037154A KR 20130037154 A KR20130037154 A KR 20130037154A KR 1020120078662 A KR1020120078662 A KR 1020120078662A KR 20120078662 A KR20120078662 A KR 20120078662A KR 20130037154 A KR20130037154 A KR 20130037154A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- mushroom
- fermentation
- mushrooms
- preparing
- Prior art date
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 83
- 239000000284 extract Substances 0.000 title claims abstract description 62
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 58
- 238000004519 manufacturing process Methods 0.000 title claims description 29
- 238000000855 fermentation Methods 0.000 claims abstract description 45
- 230000004151 fermentation Effects 0.000 claims abstract description 45
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 21
- 235000009566 rice Nutrition 0.000 claims abstract description 21
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 16
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 13
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 8
- 239000003673 groundwater Substances 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 240000007594 Oryza sativa Species 0.000 claims description 19
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 241000208340 Araliaceae Species 0.000 claims description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 235000008434 ginseng Nutrition 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 240000001980 Cucurbita pepo Species 0.000 claims description 3
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 240000003307 Zinnia violacea Species 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 239000011435 rock Substances 0.000 claims description 2
- 238000010411 cooking Methods 0.000 claims 1
- 235000019991 rice wine Nutrition 0.000 abstract description 5
- 238000005406 washing Methods 0.000 abstract description 3
- 235000001715 Lentinula edodes Nutrition 0.000 abstract description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract description 2
- 238000010025 steaming Methods 0.000 abstract description 2
- 241000209094 Oryza Species 0.000 abstract 2
- 241000414067 Inonotus obliquus Species 0.000 abstract 1
- 241000272503 Sparassis radicata Species 0.000 abstract 1
- 238000007598 dipping method Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 34
- 230000000694 effects Effects 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 21
- 229960004316 cisplatin Drugs 0.000 description 21
- 238000007654 immersion Methods 0.000 description 19
- 206010028980 Neoplasm Diseases 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 14
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 12
- 230000009471 action Effects 0.000 description 12
- 201000005202 lung cancer Diseases 0.000 description 12
- 208000020816 lung neoplasm Diseases 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 229920002498 Beta-glucan Polymers 0.000 description 5
- 241000121220 Tricholoma matsutake Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- SGJNQVTUYXCBKH-HNQUOIGGSA-N hispidin Chemical compound O1C(=O)C=C(O)C=C1\C=C\C1=CC=C(O)C(O)=C1 SGJNQVTUYXCBKH-HNQUOIGGSA-N 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- CGMQDMKDINCGOB-NJYVMNEESA-N (2s,3s)-2-(3,4-dihydroxyphenyl)-6-[(e)-2-(3,4-dihydroxyphenyl)ethenyl]-3-(4-hydroxy-6-oxopyran-2-yl)-2,3-dihydrofuro[3,2-c]pyran-4-one Chemical compound O1C(=O)C=C(O)C=C1[C@H]1C(C(=O)OC(\C=C\C=2C=C(O)C(O)=CC=2)=C2)=C2O[C@@H]1C1=CC=C(O)C(O)=C1 CGMQDMKDINCGOB-NJYVMNEESA-N 0.000 description 2
- LYKVAAQTDREPSC-DAFODLJHSA-N 2-(3,4-dihydroxyphenyl)-6-[(e)-2-(3,4-dihydroxyphenyl)ethenyl]furo[3,2-c]pyran-4-one Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(OC1=O)=CC2=C1C=C(C=1C=C(O)C(O)=CC=1)O2 LYKVAAQTDREPSC-DAFODLJHSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920001491 Lentinan Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- SGJNQVTUYXCBKH-UHFFFAOYSA-N hispidin Natural products O1C(=O)C=C(O)C=C1C=CC1=CC=C(O)C(O)=C1 SGJNQVTUYXCBKH-UHFFFAOYSA-N 0.000 description 2
- CGMQDMKDINCGOB-UHFFFAOYSA-N hypholomine B Natural products O1C(=O)C=C(O)C=C1C1C(C(=O)OC(C=CC=2C=C(O)C(O)=CC=2)=C2)=C2OC1C1=CC=C(O)C(O)=C1 CGMQDMKDINCGOB-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940115286 lentinan Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- KKWJCGCIAHLFNE-UHFFFAOYSA-N 22R-hydroxylanosterol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(C(O)CC=C(C)C)C)CCC21C KKWJCGCIAHLFNE-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- KIWODJBCHRADND-UHFFFAOYSA-N 3-anilino-4-[1-[3-(1-imidazolyl)propyl]-3-indolyl]pyrrole-2,5-dione Chemical compound O=C1NC(=O)C(C=2C3=CC=CC=C3N(CCCN3C=NC=C3)C=2)=C1NC1=CC=CC=C1 KIWODJBCHRADND-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- ZICIMKCNGGNJIZ-UHFFFAOYSA-N Hispidine Natural products C1=CC(OC)=CC=C1C(C1)=C(C=2C=C(OC)C(OC)=CC=2)CN2C1CCC2 ZICIMKCNGGNJIZ-UHFFFAOYSA-N 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- CSYGXJQNODZRQO-UHFFFAOYSA-N Inotodiol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CC(O)C12C)C4(C)CCC(O)C(C)(C)C4CC3 CSYGXJQNODZRQO-UHFFFAOYSA-N 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000013462 Interleukin-12 Human genes 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 102100024923 Protein kinase C beta type Human genes 0.000 description 1
- 101710094033 Protein kinase C beta type Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241001556385 Sanghuangporus baumii Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000006794 Volvariella volvacea Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- -1 hydroxyethyladenosine (hydroxyethyladenosine) Chemical compound 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- KKWJCGCIAHLFNE-KFPHZHIMSA-N inotodiol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H]([C@H](O)CC=C(C)C)C)CC[C@]21C KKWJCGCIAHLFNE-KFPHZHIMSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 108010030727 lens intermediate filament proteins Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/02—Preparation of other alcoholic beverages by fermentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
- C12G3/055—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides extracted from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
The present invention relates to a method for producing an anticancer fermentation product containing a mushroom extract, and more specifically, extracts including red ginseng, ginseng, ganoderma lucidum mushroom, situation mushroom, zinnia mushroom, shiitake mushroom and Cordyceps sinensis, and edible mushroom with a certain fermentation product. It relates to a method for producing an anticancer fermentation product comprising a mushroom extract to enhance anticancer activity by fermentation.
As is well known, the representative of the fermented material is liquor, bar, the beneficial enzyme is activated through the fermentation process, look at the example of the main wine Makgeolli, rice wine manufacturing method is glutinous rice, non-rice, barley, flour, etc. It is a Korean sake that is fermented by mixing malt and water. It is also known as Takju, Nongju (農 酒), Jaju (회 酒) and Hoeju (灰 酒). It is the oldest alcoholic beverage in Korea, and the color is white and turbid like hot water, and the alcohol content is 6-7 degrees.
The manufacturing method of the makgeolli manufacturing method is mainly steamed glutinous rice, non-glutinous rice, barley, wheat flour, etc., and dried water, which is called jiebab, mixed with leaven and water and fermented at a constant temperature without squeezing the sake. In the old general family, the liquor made by mixing yeast with Jiebab is placed on a crock bowl and put on a bowl of 井 -shaped, and then poured into a sieve. )
At this time, a method of manufacturing glutinous rice makgeolli, which is made of glutinous rice as raw materials, is called Dong-dongju, which is left uncooked with rice paste. A good method for producing makgeolli is sweet, sour, bitter, and astringent. It has a rich taste and a cool taste. It has been used as a farmer by relieving the thirst of farmers who sweat and work.
The alcohol content of makgeolli is similar to beer, and makgeolli is a fermented food, rich in functional ingredients such as yeast, protein, sugar, vitamin B2, and choline. Makgeolli manufacturing method and the cardiovascular disease prevention effect, the dietary fiber and protein components of the makgeolli manufacturing method is known to have an anti-cancer effect.
However, since the anticancer effect present in the rice wine manufacturing method itself is very insignificant, the anticancer effect was somewhat insufficient.
The present invention has been made in view of the above-described prior art, anti-cancer by fermenting the extract including red ginseng and ginseng, ganoderma lucidum mushroom, mushrooms, matsutake mushrooms, shiitake mushrooms and Cordyceps sinensis mushrooms and a method for producing rice wine It is an object of the present invention to provide a method for producing an anti-cancer fermented product containing a mushroom extract to enhance the action.
In order to achieve the above object, according to a preferred embodiment of the present invention, the step of semi-precipitating and increasing the steam to form a gourd rice and mixing the final state to prepare the entry, preparing a base liquor (primary hair), primary fermentation step, In the method of manufacturing makgeolli, comprising the step of obtaining the fermentation and the second fermentation, 1 liter of groundwater extracted from 150 meters of rock water as brewing water, 0.01 ml of ganoderma lucidum extract, 0.01 ml of situation mushroom extract, and 0.05 ml of mushroom mushroom extract And, mushroom extract, characterized in that the mixture of shiitake mushroom extract 0.05ml, Cordyceps sinensis extract 0.01ml, and the mushroom extract 0.05ml, red ginseng extract 0.1ml and ginseng extract 0.1ml volumetric mixture An anticancer fermentation method is provided.
Preferably, the mushroom and red ginseng and ginseng extract is separated from Ganoderma lucidum mushroom, situation mushroom, matsutake mushroom, shiitake mushroom, Cordyceps sinensis, tea mushroom, red ginseng, ginseng, respectively, after washing the roots and stems and removing foreign substances, cut to thickness 0.5㎝ And then separately put into separate containers, the drying step of drying at 50 ℃, 12 hours into a hot air precursor room; The dried materials were separately extracted with a mixture of water and ethanol in a ratio of 1: 9, and extracted 1 to 2 times in a range of 65 to 105 ° C. with a reflux extractor, and filtered using a vacuum filter. In addition, there is provided a method for producing an anticancer fermentation product comprising a mushroom extract, wherein the filtrate is prepared through an extraction process of concentrating each 60-25 Brix using a vacuum concentrator.
The anti-cancer fermented product manufacturing method including the mushroom extract according to the present invention can obtain enhanced anti-cancer effect while enjoying the fermented product, which is not comparable as a health drink, and has the advantage of using various pharmacological actions of the mushroom.
EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail with reference to drawings.
The anticancer fermentation product containing the mushroom extract according to an embodiment of the present invention undergoes a process of replacing the brewing water containing the mushroom extract with excellent anticancer effect in a process including brewing water during the process of preparing the fermentation product. It features.
The material that uses rice as a main ingredient such as makgeolli or Sikhye of representative fermentation is applicable. The raw material of makgeolli is generally rice, and rice is an important raw material for manufacturing makgeolli. The raw material affects the main quality.
General processes for the production of makgeolli are generally semi- and muddy, watery, steamed, ultimately, entry, base wine, primary fermentation, and secondary fermentation.
The manufacturing process of makgeolli first begins with a process of semi and saliva, and the purpose of the semi and saliva is to remove dust and the like adhering to the surface of rice and to absorb an appropriate amount of water. In general, the immersion time of rice depends on the net rice ratio, and the water absorption ratio after draining water is appropriate around 25 ~ 28%.
The cooker is a process of making gourd rice, and the purpose of cooker is to gelatinize the starch with strong steam of 100 ℃ or higher on the rice which absorbed water to facilitate the action of various enzymes. The steaming time is about 40 to 60 minutes, but it is controlled according to the boiler's performance. The steam is increased for about 20 to 30 minutes so that the weight of the rice is increased by 35 to 42% of the rice.
The final station refers to fungi which are used as spawns in the manufacture of the station. Usually, certain molds are bred in millet or rapeseed to contain many spores.
Entry is the artificial breeding of molds (final) after adding starch ingredients. Takju and Yakju's entry is entirely white. This is because unlike the yellow soup (黄 () strong productivity (生 酸性) because it prevents the contamination of various bacteria (술) in drunk (main).
Baekkukyun, which is widely used at present, is a kind of mutant strain that is mutated from Blackukkuk. It is called "Aspergillus. Kawachill".
Base liquor refers to the expanded culture of yeast that ferment the base liquor. Base liquor has a higher media concentration (reduced water supply), higher acidity, and lower incubation temperature compared to drunk (main).
Base liquor must contain a large amount of healthy enzymes and acids (hydrangea under citric acid, yeast under liquor: lactic acid). The presence of acid prevents contamination of germs at the base and stage 1, and furthermore, at the beginning of the stage 2 stage (main stage), even when there is the greatest risk of bacterial contamination due to inadequate yeast growth and alcohol production. It serves to prevent.
In order to manufacture a healthy base liquor (base hair), it is necessary to secure a base thread completely separated from the fermentation chamber so that various bacteria are not contaminated and cultivate or purchase a superior yeast. If you use an unhealthy base, there is a risk of dissatisfaction.
In the first fermentation, one-stage immersion refers to immersion of base liquor, entry, and water as raw materials, and is a step of expanding and cultivating yeast necessary for fermentation step by step as a second step of the base liquor manufacturing process.
The purpose of the monolith is the leaching of various enzymes and acids secreted by the entry, the self-glycosylation of the entry, and yeast growth under safe conditions.
First-stage immersion is completed by first adding water, base liquor and entry into the immersion container. The soaking temperature is about 22 ~ 28 ℃, and the soaked water will reach the time of immersion due to the saccharification of the immigration itself and the growth of yeast. The period from 1 st dip to main dip is about 5-6 days. Stir it once or twice a day during this period. The best product temperature during the first stage immersion period is 27-28 ℃.
Second fermentation is a ripening process. When only yeast (grain) is used, the first stage of immersion is the main immersion, and when the immigration is mixed or dedicated, the two stages of immersion is called main immersion. Complete the main immersion by mixing the water supply, saccharifying enzyme (leav, coenzyme, and purified enzyme) and Gwami well in one stage immersion.
This immersion product temperature is the same as the one-stage immersion product temperature. After about 5 hours after the main immersion, the immersion liquid absorbs water (leaked enzyme) enough to become saccharified and alcoholic fermentation.
Thus, the immersion maximally expands and then sinks slightly due to dissolution saccharification and fermentation. After aging, filter the liquor ants to eat.
Yeast is a kind of soup that grinds wheat and roe wheat to form dough, and then naturally breeds molds in the air to produce and secrete various enzymes. Since it has wild yeast, it is a kind of fermenting agent that acts as the mother of base wine. to be.
The brewing water in the production of makgeolli is not only a component of the product, but also a solvent of all ingredients and enzymes during the brewing process, and the trace inorganic components in the water play an important role as nutrients and stimulants of microorganisms that ferment. .
In particular, brewing water, which accounts for more than 80% of the product, has a huge impact on the quality. Therefore, it should be chosen as colorless and transparent, free from blemishes and odors, neutral to weakly alkaline, containing an appropriate amount of active ingredients, and free from harmful microorganisms and harmful components.
As a brewing water for the anticancer fermentation product containing the mushroom extract according to an embodiment of the present invention using the water drawn up from 150 meters underground, 1 day immersion, 1 day empire and room temperature (eg, 33 ℃ to 38 ℃) Final two days.
At this time, the brewing water of the anticancer fermentation product containing the mushroom extract according to an embodiment of the present invention is mixed with a certain amount of mushroom extract in 1 l of water drawn up from 150 meters underground to further enhance the anticancer action.
At this time, the mushroom extract is an extract that further comprises Ganoderma lucidum mushroom, situation mushroom, matsutake mushroom, shiitake mushroom, Cordyceps sinensis, chaga mushroom, red ginseng and ginseng extract.
The Ganoderma lucidum extract 0.01ml is mixed with 1ℓ of water, Ganoderma lucidum is the main medicinal effect in asthma, bronchitis, arthritis, hypertension, cancer treatment, etc. Ganoderma lucidum is divided into a high molecular weight component and a low molecular weight component, Are mainly immunostimulatory proteins and anticancer polysaccharides (or beta-glucans). On the other hand, the low molecular weight components are triterpenoids extracted with organic solvents and have a strong metabolite.
At this time, beta-glucan is a polymer polysaccharide that is not produced at all in the human body. These polysaccharides are more prophylactic to activate immune function than to cure diseases, lower cholesterol levels excessively in the blood, and regulate the amount of sugars that are excessively transferred, which is an essential condition for diabetics. Controlling excess cholesterol or sugar in the blood eventually clears up the blood, which inevitably improves immune function.
Beta-glucan's bio-always effects are effective against cancer, diabetes and adult diseases as well as allergic diseases and atopic dermatitis seen in infants.
At this time, the mushroom extract, including Ganoderma lucidum mushroom, mushroom mushroom, matsutake mushroom, shiitake mushroom, Cordyceps sinensis, chacha mushroom, and the extraction method of red ginseng and ginseng extract will be described below the extraction method.
Example 1: Extract Preparation
1) Drying process
After washing the roots and stems of Ganoderma lucidum mushrooms, situation mushrooms, matsutake mushrooms, shiitake mushrooms, Cordyceps sinensis mushrooms, red mushrooms, red ginseng, and ginseng, remove foreign substances, cut them into 0.5cm thick, and put them in separate containers. Put it in the hot air preheating chamber and let it dry at 50 ℃ for 12 hours.
2) Extraction and Concentration Process
The dried materials were separately extracted with a mixture of water and alcohol in a ratio of 1: 9, and extracted 1-2 times for 6 to 12 hours at a temperature of 65 to 105 ° C. using a reflux filter, followed by filtration using a vacuum filter. The filtrate was concentrated to 60-25 Brix each using a vacuum concentrator to prepare extracts of each material.
Preferably, in order to diversify the extraction concentration, the volume ratio of water and alcohol in the extraction solvent may be concentrated using a mixed solution within a range of 1: 1, 2: 1, 1: 2, 1.5: 0.5, and the like. Do.
On the other hand, the situation mushroom extract is mixed with 0.01 ml per 1 L of water, the situation mushroom is being studied for two kinds of Phellinus linteus and Phellinus baumii. Polysaccharide of the situation mushroom is expressed as an excellent anti-cancer effect, and the yellowish substance shows various pharmacological effects.
This yellow substance is a polyphenol-based pigment compound, and exhibits antioxidant activity, anti-diabetic action, dementia prevention action, antiviral action, anti-inflammatory action, cancer cell death action, platelet aggregation inhibition action and the like.
Looking only at the representative pharmacological action of the situation mushroom, as a stabilization component of the situation mushroom, components such as hispidin (hispidin), bihispidinyl, hypohymine B (hypholomine B) is known, Neil (bihispidinyl), hypolomine B (hypholomine B) is more antioxidant than hispidine.
In addition, the situation mushroom is histidine isolated from the mycelium culture medium of Linteus situation mushroom exhibits the effect of inhibiting PKC-beta to kill cancer cells more strongly than normal cells. Phenoligridin C and phellifuropyranone A in S. mushrooms also have toxic effects on human cancer cell lines.
In this case, the meaning of mixing 0.01 ml of the situation mushroom extract with respect to 1 liter of water means that 1 liter of water and 0.01 ml of the situation mushroom extract are mixed to make a mixed solution.
In addition, the flower mushroom extract is mixed with 0.05ml per 1L of water, the flower mushroom may contain antibacterial and antifungal substances, but sparan (sparan, beta-glucan) is included, so it promotes immune There is action and anticancer action.
Sparan inhibits angiogenesis and cancer metastasis in cancer-expressing mice, and is effective in lung cancer, stomach cancer, colon cancer, breast cancer and prostate cancer in human clinical trials. Sparans induce a variety of immunostimulatory cytokine secretion in human peripheral blood mononuclear cells. Sparan stimulates immunity by secreting TNF-alpha, IL-12, IFN-gamma, GM-CSF in macrophages and dendritic cells.
The shiitake mushroom is mixed with 0.05ml of shiitake mushroom extract per 1ℓ of water, shiitake mushrooms are excellent for preventing various adult diseases, inhibiting cancer cell proliferation, hypertension, diabetes, etc., and the general ingredients contain a lot of protein, fat, sugar .
Vitamins contain vitamins B1, B2 and niacin, but no vitamins A and C. Shiitake mushrooms also contain large amounts of iron that produces hemoglobin in the blood.
In addition, a special ingredient called eridadenine removes cholesterol in the blood, thereby preventing high blood pressure.
In particular, lentinan contained in shiitake mushrooms is involved in anticancer activity by increasing the activity of natural killer cells (NK cell). Lentin is a protein of 27.5 kDa molecular weight isolated from shiitake fruiting bodies. It suppresses the mycelial growth of various fungi.
The Cordyceps sinensis is mixed with 0.01ml of the Cordyceps sinensis extract per 1 liter of water. Cordyceps sinensis is a fungi parasitic and grows in insects rather than plants, and deoxyuridine among the substances contained cordyceps inhibits cancer cell growth. , 2'3'-dideoxyadenosine (2'3-dideoxyadenosine) also inhibits cancer cell growth, hydroxyethyladenosine (hydroxyethyladenosine) also inhibits cancer cell growth, cordycepic acid (cordycepic acid, D-mannitol) is an anticancer agent.
Chaga is a mixture of 0.05 ml of chaga extract per 1 L of water. Chaga is a white fungus that grows in Russia, Europe, Asia, and North America, and does not form fruiting bodies. Form a lump. These chunks are called chaga in Russian.
Among the components of chaga, inotodiol has anticancer and hypoglycemic effects, and hisslon has suppressed growth of cancer cell lines.
The red ginseng and ginseng extract is mixed at a rate of 0.1 ml each for 1 L of water, and the saponin component and non-saponin substance of red ginseng have activity to inhibit the proliferation of various types of cancer cells. The major active ingredients that inhibit the proliferation of cancer cells are G-Rh2, a saponin ingredient unique to red ginseng, and polyacetlen, an important component of fat-soluble fractions (petroleum ether extract), as a non-saponin substance. Red ginseng has a remarkable effect on the activation of natural killer cells in vivo that can kill cancer cells.
Mushrooms are known to have a variety of physiologically important effects, including antibacterial, anticancer and immune system regulation. There are many known substances that show anticancer activity in mushrooms, most of which are polysaccharides such as beta-glucan, lentinan, and lectin.
As discussed above, each mushroom extract has been shown to contain anticancer substances and have anticancer effects through long-term studies around the world, but this is an anticancer action of each mushroom extract, Although it can be proved indirectly that the anticancer makgeolli of the present invention has some effects on the anticancer properties, it does not prove the direct anticancer effect of the fermentation product containing the mushroom extract of the present invention, and it is also necessary to perform a direct experiment. I will.
Example 2: Effect of Anticancer Fermentation and Cisplatin on Anticancer Activity of Mushroom Extract
OBJECTIVES: The effect of anticancer makgeolli on cancer cell toxicity was investigated by measuring the viability of cisplatin and anticancer fermentation into cultured cancer cells.
Experimental Method:
1. Cultivation of Cells
Human lung cancer cells (A549 cells) were distributed to Korea Cell Line Bank and used for the experiment. RPMI 1640 medium (Gibco BRL) containing 10% fetal calf serum, streptomycin (100 U / ml) and penicillin (100 U / ml) was incubated at 37 ° C. in a CO 2 incubator and used for the experiment.
2. Experimental group
The experimental group was divided into anticancer fermentation group, cisplatin addition group, and anticancer fermentation product + cisplatin addition group.
The experiment was incubated for 1 day in lung cancer cells (A549 cells: 2 × 10 5 cells) in a cell culture vessel (96 well plate), the anti-cancer fermentation group added to the culture medium containing the anti-cancer fermentation product prepared in Example 1 ( Anti-cancer fermentation concentration: 0-5 mg / ml), cisplatin added group was added to cisplatin (cisplatinum: Sigma chemical Co, USA) culture solution (cisplatin concentration: 0-5 mg / ml), anti-cancer fermentation + cisplatin added group For example, the cells were cultured in a CO2 incubator for 48 hours after being exchanged with a culture solution added with an anticancer fermentation product and cisplatin (mushroom extract concentration: 0-5 mg / ml, cisplatin concentration: 0-5 mg / ml), and then cell activity (Cell viability). ) Was measured by MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl-tetrazolium bromide) method to evaluate the cellular activity by converting the absorbance of the experimental group to the control group as a ratio. Repeated experiments were carried out and expressed as average values (Table 1).
Experiment result:
(Μg / ml)
The cell activity of the control group (addition of cisplatin only) decreased the cell activity of lung cancer cells to 82% at the concentration of cisplatin at 800 μg / ml.
Cellular activity of the anticancer fermentation product of 1 mg / ㎖ of the present invention is reduced the cell activity of lung cancer cells at cisplatin concentration of 200 ㎍ / ㎖ or more, cells of lung cancer cells at cisplatin concentration of 200, 400, 600, 800 ㎍ / ㎖ Activity was 92, 88, 79 and 69%, respectively.
The cell activity of the anticancer fermented 2 mg / ml group was further decreased in the lung cancer cells at the cisplatin concentration of 200 ㎍ / ml or more, the cell activity of the lung cancer cells at the cisplatin concentration of 200, 400, 600, 800 ㎍ / ml 87, 76, 68 and 65% were shown, respectively.
Looking at the above experimental results, it can be seen that the addition of cisplatin and anti-cancer fermentation reduces the cellular activity of lung cancer cells than when adding cisplatin alone. This phenomenon is due to the anticancer action of the polysaccharides contained in mushrooms, ginseng and red ginseng. In more detail, the polysaccharides are not directly anti-cancer activity, and it is thought that cisplatin acts to increase anticancer activity against lung cancer cells.
The method for producing a fermented product using the sulfur hot spring water of the present invention is any well-known method for producing makgeolli, known in the art, specific mushroom extract and ginseng, red ginseng which can enhance anticancer activity in brewing water. It is not limited to a specific brewing method by preparing the makgeolli by mixing the extract.
On the other hand, the anticancer fermentation method manufacturing method containing a mushroom extract according to an embodiment of the present invention is not limited to only the above-described embodiment and various modifications are possible within the scope not departing from the technical gist.
Claims (2)
The mushrooms, red ginseng and ginseng extracts are each of Ganoderma lucidum mushrooms, situation mushrooms, zinnia mushrooms, shiitake mushrooms, Cordyceps sinensis, tea mushrooms, red ginseng, and ginseng. Drying each of them separately placed in a container, and putting them in a hot air precursor chamber for drying at 50 ° C. for 12 hours;
The dried materials were separately extracted with a mixture of water and ethanol in a ratio of 1: 9, and extracted 1 to 2 times in a range of 65 to 105 ° C. with a reflux extractor, and filtered using a vacuum filter. , Anti-cancer fermentation method comprising a mushroom extract, characterized in that the filtrate was prepared through an extraction process of concentrating each 60-25 Brix using a vacuum concentrator.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110101204 | 2011-10-05 | ||
KR1020110101204 | 2011-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20130037154A true KR20130037154A (en) | 2013-04-15 |
Family
ID=48438250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120078662A KR20130037154A (en) | 2011-10-05 | 2012-07-19 | Mushroom extract manufacturing method of anti-cancer efficiency |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20130037154A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016077283A (en) * | 2014-10-13 | 2016-05-16 | 農業会社法人自然生命代替医学(株) | Fermented zen food composition comprising mixture of agricultural product and cereal mycelium, for preventing cancer and diabetes and for enhancing immunity, and production method thereof |
CN106222042A (en) * | 2016-08-31 | 2016-12-14 | 贵阳名草堂绿色植物科技开发中心 | Take care of health wine |
KR101893754B1 (en) * | 2017-02-23 | 2018-08-31 | 충남대학교산학협력단 | Composition comprising inotodiol for preventing or treating of allergy |
KR20190035330A (en) * | 2017-09-26 | 2019-04-03 | 경기도 광주시 | Preparation method of Samgyetang with wild-cultivated ginseng |
WO2019225783A1 (en) * | 2018-05-24 | 2019-11-28 | 충남대학교산학협력단 | Composition comprising inotodiol compound as effective ingredient for prevention or treatment of allergy disease |
RU2713172C1 (en) * | 2019-08-22 | 2020-02-04 | Федеральное государственное бюджетное учреждение науки СИБИРСКИЙ ИНСТИТУТ ФИЗИОЛОГИИ И БИОХИМИИ РАСТЕНИЙ СИБИРСКОГО ОТДЕЛЕНИЯ РОССИЙСКОЙ АКАДЕМИИ НАУК | Method for production of inonotus rheades mycelium enriched with 6-(3,4-dihydroxystyryl)-4-hydroxy-2-pyron (hispidin) |
KR20200106660A (en) * | 2019-03-05 | 2020-09-15 | 홍순선 | Manufacturing method of rice wine containing Lentinula edodes and Sparasis crispa or the rice wine by the method |
KR102225182B1 (en) * | 2020-05-11 | 2021-03-09 | 심상희 | Freeze-dryed Makkoli and preparation method of the same |
CN116463183B (en) * | 2023-05-19 | 2024-05-03 | 泸州老窖股份有限公司 | Tartary buckwheat health wine blended with pleurotus eryngii and preparation method thereof |
-
2012
- 2012-07-19 KR KR1020120078662A patent/KR20130037154A/en active Search and Examination
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016077283A (en) * | 2014-10-13 | 2016-05-16 | 農業会社法人自然生命代替医学(株) | Fermented zen food composition comprising mixture of agricultural product and cereal mycelium, for preventing cancer and diabetes and for enhancing immunity, and production method thereof |
CN106222042A (en) * | 2016-08-31 | 2016-12-14 | 贵阳名草堂绿色植物科技开发中心 | Take care of health wine |
KR101893754B1 (en) * | 2017-02-23 | 2018-08-31 | 충남대학교산학협력단 | Composition comprising inotodiol for preventing or treating of allergy |
KR20190035330A (en) * | 2017-09-26 | 2019-04-03 | 경기도 광주시 | Preparation method of Samgyetang with wild-cultivated ginseng |
WO2019225783A1 (en) * | 2018-05-24 | 2019-11-28 | 충남대학교산학협력단 | Composition comprising inotodiol compound as effective ingredient for prevention or treatment of allergy disease |
US11896601B2 (en) | 2018-05-24 | 2024-02-13 | Carboexpert Inc. | Composition for prevention or treatment of allergic disease including inotodiol compound as active ingredient |
KR20200106660A (en) * | 2019-03-05 | 2020-09-15 | 홍순선 | Manufacturing method of rice wine containing Lentinula edodes and Sparasis crispa or the rice wine by the method |
RU2713172C1 (en) * | 2019-08-22 | 2020-02-04 | Федеральное государственное бюджетное учреждение науки СИБИРСКИЙ ИНСТИТУТ ФИЗИОЛОГИИ И БИОХИМИИ РАСТЕНИЙ СИБИРСКОГО ОТДЕЛЕНИЯ РОССИЙСКОЙ АКАДЕМИИ НАУК | Method for production of inonotus rheades mycelium enriched with 6-(3,4-dihydroxystyryl)-4-hydroxy-2-pyron (hispidin) |
KR102225182B1 (en) * | 2020-05-11 | 2021-03-09 | 심상희 | Freeze-dryed Makkoli and preparation method of the same |
CN116463183B (en) * | 2023-05-19 | 2024-05-03 | 泸州老窖股份有限公司 | Tartary buckwheat health wine blended with pleurotus eryngii and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20130037154A (en) | Mushroom extract manufacturing method of anti-cancer efficiency | |
CN102389139B (en) | Preparation method for edible fungus nutritional health-care functional drink | |
CN106085725B (en) | A kind of oligofructose " Baihuaxian " flower wine and preparation method thereof | |
CN107647371B (en) | Fig jam oil | |
KR101598291B1 (en) | Fermented Ginseng Berry Liquor, Vinegar and Method for Preparation thereof | |
CN105124597A (en) | Preparation method and application of functional monascus-fermented corn bran food | |
KR101908392B1 (en) | Manufacturing method of alcoholic beverage fermented by mushroom | |
KR101297610B1 (en) | Manufacturing method of gyrophora esculenta wine and gyrophora esculenta wine thereof | |
KR100771706B1 (en) | Method for preparing fermented alcoholic drink using arrowroot starch | |
CN107904071A (en) | A kind of processing method of shatian pomelo | |
KR101733549B1 (en) | Wine or vinegar of Orostachys japonicus made from fermented sugar extract of Orostachys japonicus | |
CN103981048A (en) | Production method of Huai Chinese yam yellow rice wine | |
CN107760552B (en) | Fig fermentation liquor and fig fruit vinegar prepared from same | |
CN105670872A (en) | Directly brewed health fresh purple sweet potato wine and production process therefor | |
KR20160075114A (en) | Preparation Metod of Vinegar Containing Coffee Extract | |
KR20170054623A (en) | Method for preparing beer using mugwort instead of hop | |
KR20190111592A (en) | Food Composition Comprising Polygonum Cuspidatum and Noble Preparation Method thereof | |
KR100850182B1 (en) | Brewing koji with improved antioxidant activity and method of producing sake thereof | |
KR20110011176A (en) | A method of producing raw rice wine containing phellinus linteus and the raw rice wine made by the method | |
KR20140094977A (en) | Method for preparing vinegar using schizandra, chinese matrimony vine and cornus officianlis | |
CN103540473B (en) | Ginseng and schisandra chinensis brewed wine and brewing process thereof | |
KR101289970B1 (en) | A method of manufacturing rice wine containing β-glucan and the rice wine by the method | |
CN106434256A (en) | Preparation method of agaricus blazei murill health vinegar | |
CN105018275A (en) | Manufacturing method for pleurotus eryngii glutinous rice wine | |
KR102073470B1 (en) | Method for manufacturing of ginseng vinegar and the ginseng vinegar manufactured thereby |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
AMND | Amendment |